Blar i forfatter Artikler, rapporter og annet (klinisk odontologi) "Al-Nawas, Bilal"

Viser treff 1-2 av 2

    • Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes 

      Jung, Ronald; Al-Nawas, Bilal; Araujo, Mauricio; Avila-Ortiz, Gustavo; Barter, Stephen; Brodala, Nadine; Chappuis, Vivianne; Chen, Bo; De Souza, Andre; Almeida, Ricardo Faria; Fickl, Stefan; Finelle, Gary; Ganeles, Jeffrey; Gholami, Hadi; Hammerle, Christoph; Jensen, Simon; Jokstad, Asbjørn; Katsuyama, Hideaki; Kleinheinz, Johannes; Kunavisarut, Chatchai; Mardas, Nikos; Monje, Alberto; Papaspyridakos, Panos; Payer, Michael; Schiegnitz, Eik; Smeets, Ralf; Stefanini, Martina; ten Bruggenkate, Christiaan; Vazouras, Konstantinos; Weber, Hans-Peter; Weingart, Dieter; Windisch, Péter (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-10-17)
      <p><i>Objectives</i>: The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and systemic (medications) factors on clinical, radiographic, and patient‐reported outcomes in implant dentistry. Focused questions on (a) short posterior dental implants (≤6 mm), (b) narrow diameter implants, (c) implant design (tapered compared to a non‐tapered ...

    • Group 3 ITI Consensus Report: Materials and antiresorptive drug-associated outcomes in implant dentistry 

      Al-Nawas, Bilal; Lambert, France; Andersen, Sanne Werner Møller; Bornstein, Michael M.; Gahlert, Michael; Jokstad, Asbjørn; Jung, Junho; Kwon, Yong-Dae; Laleman, Isabelle; Oteri, Giacomo; Roehling, Stefan; Schiegnitz, Eik; Takeda, Yukihiro; Terheyden, Hendrik (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-09-26)
      Objectives: The aim of Working Group 3 was to address the influence of both material- and anti-resorptive drug- related factors on clinical and biological outcomes and complications in implant dentistry. Focused questions were addressed on (a) implant materials other than titanium (alloy)s, (b) transmucosal abutment materials and (c) medications affecting bone metabolism were addressed.<p> <p>Materials ...